Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 222

1.

Letter to the Editor: "Effects of Testosterone Replacement on Electrocardiographic Parameters in Men: Findings From Two Randomized Trials".

Schwartz JB, Rosano G, Channer KS.

J Clin Endocrinol Metab. 2017 May 1;102(5):1787. doi: 10.1210/jc.2016-4052. No abstract available.

PMID:
28482077
2.

Testosterone differentially regulates targets of lipid and glucose metabolism in liver, muscle and adipose tissues of the testicular feminised mouse.

Kelly DM, Akhtar S, Sellers DJ, Muraleedharan V, Channer KS, Jones TH.

Endocrine. 2016 Nov;54(2):504-515. Epub 2016 Aug 4.

3.

Revascularization with percutaneous coronary intervention does not affect androgen status in males with chronic stable angina pectoris.

Gosai JN, Charalampidis P, Nikolaidou T, Parviz Y, Morris PD, Channer KS, Jones TH, Grech ED.

Andrology. 2016 May;4(3):486-91. doi: 10.1111/andr.12189. Epub 2016 Mar 29.

4.

Testosterone suppresses the expression of regulatory enzymes of fatty acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient mice.

Kelly DM, Nettleship JE, Akhtar S, Muraleedharan V, Sellers DJ, Brooke JC, McLaren DS, Channer KS, Jones TH.

Life Sci. 2014 Jul 30;109(2):95-103. doi: 10.1016/j.lfs.2014.06.007. Epub 2014 Jun 20.

PMID:
24953607
5.

Deaths and cardiovascular events in men receiving testosterone.

Jones TH, Channer KS.

JAMA. 2014 Mar 5;311(9):962-3. doi: 10.1001/jama.2014.398. No abstract available.

PMID:
24595784
6.

The role of androgen receptor CAG repeat polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes: TIMES2 sub-study.

Stanworth RD, Akhtar S, Channer KS, Jones TH.

Eur J Endocrinol. 2013 Dec 21;170(2):193-200. doi: 10.1530/EJE-13-0703. Print 2014 Feb.

PMID:
24165020
7.

Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes.

Muraleedharan V, Marsh H, Kapoor D, Channer KS, Jones TH.

Eur J Endocrinol. 2013 Oct 21;169(6):725-33. doi: 10.1530/EJE-13-0321. Print 2013 Dec.

PMID:
23999642
8.

Testosterone therapy during exercise rehabilitation in male patients with chronic heart failure who have low testosterone status: a double-blind randomized controlled feasibility study.

Stout M, Tew GA, Doll H, Zwierska I, Woodroofe N, Channer KS, Saxton JM.

Am Heart J. 2012 Dec;164(6):893-901. doi: 10.1016/j.ahj.2012.09.016. Epub 2012 Oct 30.

PMID:
23194490
9.

Effect of Testosterone on Inflammatory Markers in the Development of Early Atherogenesis in the Testicular-Feminized Mouse Model.

Kelly DM, Sellers DJ, Woodroofe MN, Jones TH, Channer KS.

Endocr Res. 2013 Aug;38(3):125-138. doi: 10.3109/07435800.2012.735307. Epub 2012 Nov 20.

PMID:
23167461
10.

Focal pulmonary oedema: an unusual presentation of acute mitral regurgitation.

Morris PD, Warriner DR, Channer KS.

Thorax. 2013 May;68(5):498. doi: 10.1136/thoraxjnl-2012-202420. Epub 2012 Oct 31. No abstract available.

PMID:
23117982
11.

Reversible heart failure: toxins, tachycardiomyopathy and mitochondrial abnormalities.

Morris PD, Robinson T, Channer KS.

Postgrad Med J. 2012 Dec;88(1046):706-12. doi: 10.1136/postgradmedj-2011-130698. Epub 2012 Jun 28. Review.

PMID:
22745181
12.

Testosterone and cardiovascular disease in men.

Morris PD, Channer KS.

Asian J Androl. 2012 May;14(3):428-35. doi: 10.1038/aja.2012.21. Epub 2012 Apr 23.

13.

Dyslipidaemia is associated with testosterone, oestradiol and androgen receptor CAG repeat polymorphism in men with type 2 diabetes.

Stanworth RD, Kapoor D, Channer KS, Jones TH.

Clin Endocrinol (Oxf). 2011 May;74(5):624-30. doi: 10.1111/j.1365-2265.2011.03969.x.

PMID:
21470285
14.

Testosterone replacement in hypogonadal men with type 2 diabetes and/or metabolic syndrome (the TIMES2 study).

Jones TH, Arver S, Behre HM, Buvat J, Meuleman E, Moncada I, Morales AM, Volterrani M, Yellowlees A, Howell JD, Channer KS; TIMES2 Investigators.

Diabetes Care. 2011 Apr;34(4):828-37. doi: 10.2337/dc10-1233. Epub 2011 Mar 8.

15.

Endogenous testosterone levels and cardiovascular disease in healthy men.

Channer KS.

Heart. 2011 Jun;97(11):867-9. doi: 10.1136/hrt.2010.217414. Epub 2011 Feb 8. No abstract available.

PMID:
21303797
16.

Reversible heart failure: the role of inflammatory activation.

Robinson T, Smith A, Channer KS.

Postgrad Med J. 2011 Feb;87(1024):110-5. doi: 10.1136/pgmj.2010.100123. Epub 2010 Nov 19. Review.

PMID:
21097545
17.

Low serum testosterone and increased mortality in men with coronary heart disease.

Malkin CJ, Pugh PJ, Morris PD, Asif S, Jones TH, Channer KS.

Heart. 2010 Nov;96(22):1821-5. doi: 10.1136/hrt.2010.195412. Epub 2010 Oct 19.

PMID:
20959649
18.

Testosterone and heart failure.

Malkin CJ, Channer KS, Jones TH.

Curr Opin Endocrinol Diabetes Obes. 2010 Jun;17(3):262-8. doi: 10.1097/MED.0b013e328339543e. Review.

PMID:
20404724
19.

Neuroendocrine effects on the heart and targets for therapeutic manipulation in heart failure.

Chaggar PS, Malkin CJ, Shaw SM, Williams SG, Channer KS.

Cardiovasc Ther. 2009 Fall;27(3):187-93. doi: 10.1111/j.1755-5922.2009.00094.x. Review.

PMID:
19689618
20.

Testosterone acts as an efficacious vasodilator in isolated human pulmonary arteries and veins: evidence for a biphasic effect at physiological and supra-physiological concentrations.

Rowell KO, Hall J, Pugh PJ, Jones TH, Channer KS, Jones RD.

J Endocrinol Invest. 2009 Oct;32(9):718-23. doi: 10.3275/6361.

PMID:
19535892
21.

Chronic atrial fibrillation: a systematic review of medical heart rate control management.

Nikolaidou T, Channer KS.

Postgrad Med J. 2009 Jun;85(1004):303-12. doi: 10.1136/pgmj.2008.068908. Review.

PMID:
19528305
22.

Mechanisms of agonist-induced constriction in isolated human pulmonary arteries.

Hall J, Jones TH, Channer KS, Jones RD.

Vascul Pharmacol. 2009 Jul;51(1):8-12. doi: 10.1016/j.vph.2009.01.007. Epub 2009 Feb 3.

PMID:
19275965
23.

Statin therapy is associated with lower total but not bioavailable or free testosterone in men with type 2 diabetes.

Stanworth RD, Kapoor D, Channer KS, Jones TH.

Diabetes Care. 2009 Apr;32(4):541-6. doi: 10.2337/dc08-1183. Epub 2008 Dec 29.

24.

Current issues in thromboprophylaxis in the elderly.

Chaggar PS, Channer KS.

Drugs Aging. 2008;25(12):1049-60. doi: 10.2165/0002512-200825120-00006. Review.

PMID:
19021303
25.

Androgen receptor CAG repeat polymorphism is associated with serum testosterone levels, obesity and serum leptin in men with type 2 diabetes.

Stanworth RD, Kapoor D, Channer KS, Jones TH.

Eur J Endocrinol. 2008 Dec;159(6):739-46. doi: 10.1530/EJE-08-0266. Epub 2008 Sep 19.

PMID:
18805913
26.

Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetes.

Kapoor D, Channer KS, Jones TH.

Diab Vasc Dis Res. 2008 Jun;5(2):135-7. doi: 10.3132/dvdr.2008.022.

PMID:
18537102
27.

The triad of erectile dysfunction, hypogonadism and the metabolic syndrome.

Shabsigh R, Arver S, Channer KS, Eardley I, Fabbri A, Gooren L, Heufelder A, Jones H, Meryn S, Zitzmann M.

Int J Clin Pract. 2008 May;62(5):791-8. doi: 10.1111/j.1742-1241.2008.01696.x. Epub 2008 Feb 2. Review.

28.

Sexual health as a portal to men's health: a problem turned around into an opportunity.

Shabsigh R, Arver S, Channer KS, Eardley I, Fabbri A, Gooren L, Heufelder A, Jones H, Meryn S, Zitzmann M.

Int J Clin Pract. 2008 Feb;62(2):179-81. doi: 10.1111/j.1742-1241.2007.01657.x. No abstract available.

29.

Characterization of the vasodilatory action of testosterone in the human pulmonary circulation.

Smith AM, Bennett RT, Jones TH, Cowen ME, Channer KS, Jones RD.

Vasc Health Risk Manag. 2008;4(6):1459-66.

30.

Rate control in permanent atrial fibrillation.

Nikolaidou T, Channer KS.

BMJ. 2007 Nov 24;335(7629):1057-8. No abstract available.

31.
32.
34.

Association analysis of IL-12B and IL-23R polymorphisms in myocardial infarction.

Mangino M, Braund P, Singh R, Steeds R, Stevens S, Channer KS, Samani NJ.

J Mol Med (Berl). 2008 Jan;86(1):99-103. Epub 2007 Sep 28.

PMID:
17901940
35.

Inverse relationship between serum levels of interleukin-1beta and testosterone in men with stable coronary artery disease.

Nettleship JE, Pugh PJ, Channer KS, Jones T, Jones RD.

Horm Metab Res. 2007 May;39(5):366-71.

PMID:
17533579
36.

The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes.

Kapoor D, Clarke S, Stanworth R, Channer KS, Jones TH.

Eur J Endocrinol. 2007 May;156(5):595-602.

PMID:
17468196
37.
38.

A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO).

Rash A, Downes T, Portner R, Yeo WW, Morgan N, Channer KS.

Age Ageing. 2007 Mar;36(2):151-6. Epub 2006 Dec 15.

PMID:
17175564
40.

The effect of testosterone on insulin sensitivity in men with heart failure.

Malkin CJ, Jones TH, Channer KS.

Eur J Heart Fail. 2007 Jan;9(1):44-50. Epub 2006 Jul 7.

41.
42.

Effect of testosterone on ex vivo vascular reactivity in man.

Malkin CJ, Jones RD, Jones TH, Channer KS.

Clin Sci (Lond). 2006 Oct;111(4):265-74.

PMID:
16722820
43.

Junior doctors and the full shift rota--psychological and hormonal changes: a comparative cross-sectional study.

Smith AM, Morris P, Rowell KO, Clarke S, Jones TH, Channer KS.

Clin Med (Lond). 2006 Mar-Apr;6(2):174-7.

44.

Coronary artery disease in men: the role of sex hormones.

Channer KS.

Future Cardiol. 2006 May;2(3):247-50. doi: 10.2217/14796678.2.3.247. No abstract available.

45.

Mechanisms of agonist-induced constriction in isolated human mesenteric arteries.

Hall J, Jones TH, Channer KS, Jones RD.

Vascul Pharmacol. 2006 Jun;44(6):427-33. Epub 2006 Apr 19.

PMID:
16624627
46.

Selective inhibition of L-type Ca2+ channels in A7r5 cells by physiological levels of testosterone.

Hall J, Jones RD, Jones TH, Channer KS, Peers C.

Endocrinology. 2006 Jun;147(6):2675-80. Epub 2006 Mar 9.

PMID:
16527846
47.
48.

The role of vasopressin in cardiorespiratory arrest and pulmonary hypertension.

Smith AM, Elliot CM, Kiely DG, Channer KS.

QJM. 2006 Mar;99(3):127-33. Epub 2006 Feb 8. Review.

PMID:
16467356
49.

Physiologic testosterone therapy has no effect on serum levels of tumour necrosis factor-alpha in men with chronic heart failure.

Pugh PJ, Jones RD, Malkin CJ, Hall J, Nettleship JE, Kerry KE, Jones TH, Channer KS.

Endocr Res. 2005;31(4):271-83.

PMID:
16433247
50.

Androgens, insulin resistance and vascular disease in men.

Kapoor D, Malkin CJ, Channer KS, Jones TH.

Clin Endocrinol (Oxf). 2005 Sep;63(3):239-50. Review.

PMID:
16117808

Supplemental Content

Loading ...
Support Center